Reading a KLOW certificate of analysis requires a slightly different approach than reading a single-compound COA. KLOW is a four-component blend — GHK-Cu, BPC-157, TB-500, and KPV — and the klow peptide coa covers the finished formulation after those components are combined. Each constituent brings its own mass spectrometry signature and its own contribution to the HPLC chromatogram. Understanding how a multi-component COA is structured keeps you from misreading what the data is actually telling you.
The sections below walk through what a complete KLOW certificate should contain and what warrants closer attention.
Lot Number and Test Date
Every valid COA begins with a lot number tied to a specific production batch. KLOW, at 80mg per vial, is a precision blend — small variation in component ratios or synthesis conditions across runs is exactly why lot traceability exists. The lot number connects the analytical results to the manufacturing record for that specific batch.
Test date matters for two reasons. First, it establishes when the documented measurements were taken. Second, it helps verify that the certificate is current relative to the compound’s shelf life under proper storage conditions (−20°C for the lyophilized powder). A certificate from more than 12 months before shipment is worth querying from the supplier, even when lot numbers match and storage has been correct.
The lot number on the certificate should match what appears on the vial label. A discrepancy is a documentation control failure. Contact the supplier before proceeding with any use of the material.
Identity and Purity by HPLC
The HPLC section of a blend COA like KLOW looks different from a single-compound trace. With four active peptides present — GHK-Cu at approximately 341.4 Da, BPC-157 at approximately 1419.5 Da, TB-500 fragment at approximately 778 Da, and KPV at approximately 324.4 Da — the chromatogram reflects the combined signal of all components rather than a clean single-peak output.
A well-documented blend COA will annotate the chromatogram to identify which peak corresponds to which component by retention time or reference standard. If the certificate shows only a single unresolved mass with no component attribution, it is providing significantly less information than the data should yield.
Purity should be stated as >99%, and the COA should provide the actual numeric result for this specific lot rather than only the specification threshold. The result — “99.2% by RP-HPLC, UV 220 nm,” for example — is what tells you whether this batch cleared the standard and by how much.
GHK-Cu sourced as a standalone vial carries the same purity and documentation requirement. If you’re comparing a KLOW COA against an individual GHK-Cu COA, the purity data should align in terms of analytical method and reporting format.
Mass Spectrometry Data
Mass spectrometry confirms compound identity in ways that HPLC cannot. Where HPLC shows that dominant peaks are present, MS establishes what those peaks actually are.
For a four-component blend, a complete MS report should account for each constituent. GHK-Cu will appear at its characteristic mass. BPC-157 at ~1419.5 Da should produce a clear signal. TB-500 fragment and KPV, each at lower masses, should be detectable as distinct species.
If the MS report covers only the most prominent peak without annotating the smaller components, it is a partial report. A supplier who can provide the full mass spectrum data should be able to do so on request, and a hesitation to share it is worth noting.
Bacterial Endotoxin Testing
Bacterial endotoxin testing is the section most often underweighted when reviewing a COA — particularly for blend formulations. Endotoxins are lipopolysaccharide fragments shed from gram-negative bacterial cell walls during synthesis or handling, and they are entirely invisible to chromatography and mass spectrometry. A separate dedicated assay is required to detect them.
KLOW, as a blend studied in contexts where inflammatory and regenerative pathways are under examination, represents a case where endotoxin contamination would be especially disruptive. Contamination that triggers cytokine release or systemic immune activation confounds readouts in the study contexts most relevant to KLOW research.
The COA should report a numeric endotoxin result in EU/mg alongside the pass/fail designation. A result without a value gives no margin information. Research-grade specifications typically set ≤1 EU/mg as the acceptable limit; well-produced lots come in well below that.
KLOW certificates from Freedom Diagnostics and Horizon Analytical include numeric endotoxin values, not just pass/fail notations. The lab name matters — results from a named external lab are attributable and independently verifiable in a way that “internal QC pass” is not.
Additional Quality Indicators
Appearance. The COA may include a visual description of the lyophilized product — typically white to off-white powder. Any physical discrepancy between what you receive and the description on the certificate should be flagged before use.
Water content. Some certificates include Karl Fischer titration or loss-on-drying results showing residual moisture levels. High moisture content in lyophilized peptides is associated with faster degradation during storage, particularly for compounds like KPV and GHK-Cu that can be sensitive to hydrolytic conditions. Not every supplier includes this measurement, but its presence indicates more complete manufacturing oversight.
Certifying lab. The lab named on the certificate should be an independent third-party analytical facility. Self-issued certificates can be formatted to look like third-party documents. Cross-check the lab name against recognizable independent providers.
BPC-157 and KPV sourced as individual vials follow the same COA documentation standard. Researchers comparing documentation quality across blend and standalone formats will find the same sections — HPLC purity, MS identity, and endotoxin data — should appear in both.
FAQ
Why does a KLOW COA show multiple peaks in the HPLC chromatogram rather than one clean peak?
Because KLOW contains four active compounds. Each one produces a distinct peak at its characteristic retention time in the chromatogram. A single-compound COA produces a dominant peak with minimal satellite signal; a properly resolved blend chromatogram shows peaks for each constituent. The key is whether the COA annotates those peaks by component or presents an unresolved profile that makes it impossible to evaluate individual compound presence.
What is the significance of the lot number on my KLOW vial?
The lot number ties your vial to a specific production run with its own synthesis records, raw material sourcing documentation, and analytical results. If a quality concern arises — unusual physical appearance, unexpected potency, suspected contamination — the lot number is how the supplier isolates the issue to a specific batch rather than treating it as a general product question. Record the lot number at time of receipt.
How do I interpret a KLOW purity result versus purity results for individual peptides?
For single peptides, >99% purity means more than 99% of the detected material is the target compound. For a blend like KLOW, the interpretation shifts: purity reflects the overall quality of the final formulation, with the figure indicating that minimal impurities or degradation products are present across all components combined. The analytical basis remains the same — HPLC with supporting MS identity data. What changes is the complexity of the chromatogram, not the standard the product must meet.
All products discussed are for laboratory research use only and are not for human or veterinary use.